Robert J. Sheehy - 06 May 2021 Form 4 Insider Report for Bright Health Group Inc. (NEUE)

Role
CHAIRMAN OF THE BOARD, Director
Signature
/s/ Eric Halverson for Robert J. Sheehy, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
06 May 2021
Net transactions value
$0
Form type
4
Filing time
30 Jun 2021, 21:50:22 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHG Common Stock Gift $0 -15,765,831 -100% $0.000000* 0 06 May 2021 Direct
transaction BHG Common Stock Gift $0 +15,765,831 +537% $0.000000 18,701,517 06 May 2021 By Robert J. Sheehy Revocable Trust F1
transaction BHG Common Stock Conversion of derivative security +832,604 +4.5% 19,534,121 28 Jun 2021 By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Common Stock Conversion of derivative security +521,115 +2.7% 20,055,236 28 Jun 2021 By Robert J. Sheehy Revocable Trust F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHG Series A Preferred Stock Gift $0 -248,115 -100% $0.000000* 0 06 May 2021 Common Stock 168,407 Direct F2
transaction BHG Series A Preferred Stock Gift $0 +248,115 +25% $0.000000 1,226,677 06 May 2021 Common Stock 168,407 By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Series A Preferred Stock Conversion of derivative security $0 -1,226,677 -100% $0.000000* 0 28 Jun 2021 Common Stock 832,604 By Robert J. Sheehy Revocable Trust F1, F2
transaction BHG Series B Preferred Stock Conversion of derivative security $0 -173,705 -100% $0.000000* 0 28 Jun 2021 Common Stock 521,115 By Robert J. Sheehy Revocable Trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person is trustee.
F2 Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.
F3 Each share of the Issuer's Series B Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date.